Cooperative Newborn Screening System Priorities Program (NBS Co-Propel)

Active
No
Status
Posted
Published Date
November 21st, 2023
Close Date
February 23rd, 2024
Total Funding
$4,000,000.00
Award Ceiling
$500,000.00
Award Floor
$0.00
Expected No. Awards
10
Opportunity No.
HRSA-24-052

Agency

Health Resources and Services Administration (HHS-HRSA)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The Health Resources and Services Administration is offering funding through the Cooperative Newborn Screening System Priorities Program (NBS Co-Propel). This program aims to strengthen the newborn screening (NBS) system to provide screening, counseling, and health care services to newborns and children with, or at risk for, heritable disorders. The funding will support up to 10 recipients to address state/territory-specific challenges and pursue priorities to enhance, improve, and expand their NBS System. It will also focus on increasing timely collection and reporting of NBS specimens to improve early diagnosis and treatment for individuals with heritable conditions identified through NBS. Additionally, the funding will support long-term follow-up for individuals with Severe Combined Immunodeficiency (SCID) and other NBS conditions, linking public health agencies, clinicians, and engaging families. The program objectives include increasing the number of NBS specimens collected within 48 hours of birth, improving the communication of presumptive positive results for time-critical conditions, and increasing the reporting of NBS results within 7 days of birth. The program also aims to develop data collection plans to measure the percentage of 3-year-old children with at least one heritable condition identified through NBS who are thriving. Organizations in the United States, including state or political subdivisions, territories, health facilities or programs operated by or pursuant to a contract with or grant from the Indian Health Services, and other entities with appropriate expertise in NBS, are eligible to apply. The deadline for applications is February 23, 2024. For more information, please visit the following link: link. For any inquiries, contact Loraine Swanson, MPH at (404)234-3557 or email LSwanson@hrsa.gov.

Description

This notice announces the opportunity to apply for funding under the Cooperative Newborn Screening System Priorities Program (NBS Co-Propel). The purpose of this program is to strengthen the newborn screening (NBS) system to provide screening, counseling, and health care services to newborns and children with, or at risk for, heritable disorders and help them achieve the best possible outcomes. Funding will support up to 10 recipients to 1) address state/territory-specific challenges and pursue priorities to enhance, improve, and expand their NBS System; 2) increase timely collection and reporting of NBS specimens to improve early diagnosis and treatment for individuals with heritable conditions identified through NBS; and 3) support long-term follow-up (LTFU) for individuals with Severe Combined Immunodeficiency (SCID) and other NBS conditions that link public health agencies, clinicians, and meaningfully engages and partners with families. Goal NBS Co-Propel builds on previously funded HRSA grants to strengthen collaborations between state/territory public health agencies and with NBS partners such as universities, non-profits, or other institutions with expertise in NBS to achieve a common goal: to improve access to services and outcomes for children identified with a heritable condition through NBS so they are healthy, growing, and thriving. NBS Co-Propel has two focus areas: Focus Area 1 includes activities related to improving collection of specimens, testing of specimens, and reporting out of results, including improving the timeliness of these activities; and implementing screening for newly added RUSP conditions. Focus Area 2 includes activities related to improving short-term follow-up through long-term follow-up and helping families understand and navigate the process from confirmation of a diagnosis to treatment, and through follow-up across the lifespan. These activities include expanding access to diagnosis and treatment resources for providers and families of infants with SCID and other NBS disorders with a focus on reaching underserved populations, and empowering families to actively engage at all levels of the NBS system. Program Objectives • By June 2028, increase by 5 percent the number of NBS specimens collected within 48 hours of birth. • By June 2028, increase by 10 percent the presumptive positive results for time-critical conditions that are communicated immediately to the newborn’s healthcare provider but no later than five days of birth. • By June 2028, increase by 5 percent of all NBS results (normal and out-of-range) that are reported within 7 days of birth, overall and for all races and ethnicities. • By June 2028, state/territory NBS program collects and reports on at least one NBS Long Term Follow Up Quality Indicator for at least one heritable condition identified through dried blood spot screening. • By June 2028, state/territory NBS program has a data collection plan developed in collaboration with NBS Excel to measure the percentage of 3-year-old children with at least one heritable condition identified through NBS who are thriving. All data and plans must be submitted to the recipient of NBS Excel (HRSA-23-077).

Contact Information

Attachments
137 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)". This grant aims to support research that focuses on the development of new screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. The grant also seeks to address "high priority" genetic conditions where screening may be possible in the near future. The grant emphasizes the importance of accurate screening tests and demonstrating the benefits of early intervention or treatment for including a condition on a newborn screening panel. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The category of funding activity is Income Security and Social Services. The opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The closing date for this grant opportunity is November 5, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-353.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-353.html). For any inquiries, please refer to the contact information provided in Section VII. Agency Contacts within the full opportunity announcement.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)". This grant aims to support research related to the development of new screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also focuses on "high priority" genetic conditions where screening may be possible in the near future. The grant seeks to identify accurate screening tests and demonstrate the benefits of early intervention or treatment for these conditions. The funding amount for this grant is up to $50,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is November 16, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-354.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-354.html).
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)". This grant aims to support research focused on the development of new screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. The grant also targets "high priority" genetic conditions where screening may be possible in the near future. The grant encourages the development of accurate screening tests and the demonstration of the benefits of early intervention or treatment for these conditions. The maximum award ceiling for this grant is $275,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is November 16, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-355.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-355.html). For any inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.